13.8.2026 15:04:26 CEST | Demant A/S |
Ledende medarbejderes transaktioner
Selskabsmeddelelse nr. 2026-10
13. august 2026
Ledende medarbejderes og disses nærtståendes transaktioner med Demant-aktier
Indberetning i henhold til markedsmisbrugsforordningens artikel 19.
1.
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
a)
Navn
Thomas Hofman-Bang
2.
Årsag til indberetningen
a)
Stilling/titel
Bestyrelsesmedlem
b)
Første indberetning/ændring
Første indberetning
3.
Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførende
a)
Navn
Demant A/S
b)
LEI-kode
213800RM6L9LN78BVA56
4.
Nærmere oplysninger om transaktionen/transaktionerne: Gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner
a)
Beskrivelse af det finansielle
instrument, instrumenttypen
Identifikationskode
Aktier
DK0060738599
b)
Transaktionens art
Køb
c)
Pris(er) og mængde(r)
Pris(er) Mængde(r)
DKK 288,80 pr. aktie 17.224 stk. aktier
d)
Aggregerede oplysninger:
– Aggregeret mængde
– Pris
Aggregeret mængde: 17.224 stk. aktier
Aggregeret pris: DKK 4.974.291,20
e)
Dato for transaktionen
12. august 2026
f)
Sted for transaktionen
Nasdaq Copenhagen A/S
Yderligere information:
Søren Nielsen, koncernchef & adm. direktør
Telefon +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
René Schneider, CFO
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Alonso Francisco, Communication Manager
Kontakter
Maribel Alonso Francisco, Communication Manager, +45 3171 9261, msbl@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 26,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
Vedhæftninger
2026-10 Ledende medarbejderes og disses nærtståendes transaktioner med Demant-aktier.pdf
13.8.2026 15:04:26 CEST | Demant A/S |
Managers' Transactions
Company announcement no 2026-10
13 August 2026
Transactions with Demant shares by managers and closely associated parties
Notification pursuant to article 19 of the Market Abuse Regulation.
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Thomas Hofman-Bang
2.
Reason for the notification
a)
Position/status
Member of the Board of Directors
b)
Initial notification/amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Shares
DK0060738599
b)
Nature of the transaction
Purchase
c)
Price(s) and volume(s)
Price(s) Volume(s)
DKK 288.80 per share 17,224 shares
d)
Aggregated information:
– Aggregated volume
– Price
Aggregated volume: 17,224 shares
Aggregated price: DKK 4,974,291.20
e)
Date of the transaction
12 August 2026
f)
Place of the transaction
Nasdaq Copenhagen A/S
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Alonso Francisco, Communication Manager
Contacts
Maribel Alonso Francisco, Communication Manager, +45 3171 9261, msbl@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 26,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
Attachments
2026-10 Managers and closely associated parties transactions with Demant shares.pdf
